Post-operative minimal residual disease models to study metastatic relapse in soft-tissue sarcoma patient-derived xenografts
Clin Transl Med
.
2023 Jun;13(6):e1290.
doi: 10.1002/ctm2.1290.
Authors
Suzanne Fischer
1
2
3
,
David Creytens
3
4
,
Sofie De Geyter
1
,
Elly De Vlieghere
1
3
,
Piet Pattyn
2
,
Sarah-Lee Bekaert
3
5
,
Kaat Durinck
3
6
7
,
Nadine Van Roy
3
5
6
,
An Hendrix
1
3
,
Lore Lapeire
3
8
,
Gwen Sys
3
9
,
Olivier De Wever
1
3
Affiliations
1
Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
2
Department of Gastro-Intestinal Surgery, Ghent University Hospital, Ghent, Belgium.
3
Cancer Research Institute Ghent, Ghent, Belgium.
4
Department of Pathology, Ghent University Hospital, Ghent, Belgium.
5
Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
6
Pediatric Precision Oncology Lab, Ghent University, Ghent, Belgium.
7
Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
8
Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
9
Department of Orthopedics and Traumatology, Ghent University Hospital, Ghent, Belgium.
PMID:
37282823
PMCID:
PMC10244893
DOI:
10.1002/ctm2.1290
No abstract available
Publication types
Letter
MeSH terms
Animals
Disease Models, Animal
Heterografts
Humans
Neoplasm Recurrence, Local
Neoplasm, Residual
Sarcoma* / pathology
Sarcoma* / surgery
Soft Tissue Neoplasms* / pathology
Soft Tissue Neoplasms* / surgery